Interventional Pulmonology Fellowship Training
Interventional pulmonology (IP) fellowship training is a structured post-fellowship program that prepares pulmonologists to perform advanced diagnostic and therapeutic bronchoscopic and pleural procedures. This page covers the program structure, accreditation framework, procedural scope, and the decision boundaries that distinguish IP practice from standard pulmonary or critical care roles. The field has grown substantially as minimally invasive techniques replace open surgical approaches for lung cancer staging, airway disease management, and pleural disorders.
Definition and scope
Interventional pulmonology is a recognized subspecialty of pulmonary medicine focused on advanced endoscopic and image-guided procedures of the airways, lungs, and pleural space. Physicians entering IP fellowship have already completed a standard pulmonary and critical care fellowship accredited by the Accreditation Council for Graduate Medical Education (ACGME).
IP fellowship training itself is governed through a combination of ACGME program requirements for procedural subspecialty training and standards published by the American Association for Bronchology and Interventional Pulmonology (AABIP). The AABIP publishes a consensus curriculum and minimum procedure volume thresholds that training programs use to benchmark competency. Programs typically span 12 months, though some centers offer 24-month tracks that incorporate research or additional complex procedural exposure.
The procedural scope of IP training encompasses three broad domains:
- Advanced diagnostic bronchoscopy — endobronchial ultrasound (EBUS), electromagnetic navigation bronchoscopy (ENB), radial probe ultrasound, and robotic bronchoscopy platforms
- Therapeutic airway procedures — rigid bronchoscopy, airway stenting, balloon bronchoplasty, laser and argon plasma coagulation (APC), cryotherapy, and bronchial thermoplasty
- Pleural interventions — medical thoracoscopy (pleuroscopy), tunneled pleural catheter placement, chemical pleurodesis, and ultrasound-guided thoracentesis at an advanced level
This scope distinguishes IP from general bronchoscopic interventions performed by standard pulmonologists, which typically exclude rigid bronchoscopy and medical thoracoscopy. The broader regulatory context for pulmonary medicine shapes how procedures are credentialed and reimbursed at institutional and payer levels.
How it works
IP fellowship training follows a phased competency model. The AABIP consensus document, last formally updated and widely cited in the literature, specifies minimum procedural volumes including at least 40 EBUS-transbronchial needle aspiration (EBUS-TBNA) procedures and at least 20 medical thoracoscopies to establish baseline competency. These thresholds inform but do not replace institutional credentialing determinations made by hospital privileging committees.
The training structure typically progresses through three phases:
- Orientation and supervised observation (months 1–2): Fellows observe cases, review bronchoscopic anatomy with simulation trainers, and complete required didactic modules. Simulation-based training using airway mannequins and ex vivo tissue models is a standard component.
- Graduated procedural participation (months 3–9): Fellows perform procedures under direct attending supervision, with progressive autonomy as volume and competency benchmarks are reached. Logbooks are maintained and reviewed at formal evaluations.
- Independent procedural practice with oversight (months 10–12): Fellows manage complex cases and multidisciplinary tumor board presentations with attending availability but reduced direct scrub supervision.
Programs affiliated with academic medical centers are the dominant training sites because volume requirements for rare procedures — rigid bronchoscopy for central airway obstruction management, for example — demand a tertiary referral base. The pulmonary authority index reflects the scope of subspecialty fields that build upon core pulmonary training.
Common scenarios
IP fellowship-trained physicians are deployed in several high-acuity clinical contexts:
- Lung cancer staging and tissue acquisition: EBUS-TBNA is the primary modality for sampling mediastinal and hilar lymph nodes before surgical resection. The American College of Chest Physicians (ACCP) guidelines endorse EBUS as a first-line procedure for mediastinal staging in non-small cell lung cancer (NSCLC), reducing the rate of unnecessary surgical mediastinoscopy.
- Central airway obstruction (CAO): Malignant or benign obstruction of the trachea or mainstem bronchi requires debulking via laser, APC, cryorecanalization, or mechanical rigid bronchoscopy, followed by stent placement. CAO management is exclusively within the IP procedural domain.
- Malignant pleural effusion: IP fellows develop competency in tunneled pleural catheter (TPC) placement and medical thoracoscopy for diagnosis and pleurodesis in patients with recurrent pleural effusion from malignancy.
- Peripheral pulmonary lesion biopsy: ENB and robotic bronchoscopy platforms are used for biopsy of peripheral nodules, particularly those identified through lung cancer screening programs, where CT-guided transthoracic biopsy carries higher pneumothorax risk in emphysematous lungs.
- Bronchial thermoplasty: Reserved for severe, refractory asthma uncontrolled by pharmacotherapy, this thermal ablation procedure targeting airway smooth muscle is an IP-exclusive intervention approved by the FDA.
Decision boundaries
IP fellowship training occupies a defined procedural niche between standard pulmonary medicine and thoracic surgery. Three boundaries define where IP practice begins and ends:
IP vs. general pulmonology: General pulmonologists perform flexible bronchoscopy with bronchoalveolar lavage, endobronchial biopsy, and basic transbronchial biopsy. IP adds rigid bronchoscopy, EBUS, ENB, stenting, and medical thoracoscopy — procedures that require dedicated fellowship training beyond ACGME pulmonary-critical care requirements.
IP vs. thoracic surgery: The pulmonology vs. thoracic surgery distinction becomes clinically relevant when lesions or airway pathology require open or video-assisted thoracoscopic surgery (VATS). IP manages endobronchial and pleural disease through natural orifice or percutaneous approaches; thoracic surgeons manage resection, reconstruction, and cases where endoscopic access is anatomically or oncologically insufficient.
IP credentialing vs. IP training: Completing fellowship training does not automatically confer hospital privileges. Each institution's medical staff office reviews procedure logs, training attestation, and outcome data independently. The Society for Interventional Pulmonology (SIP) and AABIP both publish position statements on credentialing standards that hospitals may reference but are not federally mandated to adopt.
References
- Accreditation Council for Graduate Medical Education (ACGME) — graduate medical education accreditation standards
- American Association for Bronchology and Interventional Pulmonology (AABIP) — IP fellowship curriculum and procedural volume consensus
- American College of Chest Physicians (ACCP) — Chest Guidelines — mediastinal staging and EBUS guideline recommendations
- U.S. Food and Drug Administration (FDA) — Bronchial Thermoplasty Device Approval — device approval documentation for bronchial thermoplasty systems
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)